Severe Thrombocytopenia After Dasatinib Treatment in a Patient With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s83961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.

Internal Medicine
Internal MedicineMedicine
2002English

Philadelphia Chromosome‐negative Acute Leukemia in Chronic Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Gynecomastia in a Male After Dasatinib Treatment for Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Dasatinib Induces Severe Hemorrhagic Colitis in a Patient With Accelerated Phase of Chronic Myelogenous Leukemia

Korean Journal of Internal Medicine
Internal Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy